Rhabdomyolysis in a hepatitis C virus infected patient treated with telaprevir and simvastatin by de Kanter, Clara T.M.M, van Luin, Matthijs, Solas, Caroline, Burger, David M, Vrolijk, Jan Maarten

Get full text

Natural history and treatment of HCV/HIV coinfection: Is it time to change paradigms? by Arends, Joop E, Lieveld, Faydra I, Boeijen, Lauke L, de Kanter, Clara T.M.M, van Erpecum, Karel J, Salmon, Dominique, Hoepelman, Andy I.M, Asselah, Tarik, Ustianowski, Andrew

Get full text

Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis by de Kanter, Clara T.M.M, den Hollander, Jan G, Verweij-van Wissen, Corrien P.W.G.M, Burger, David M

Get full text

Managing drug–drug interactions in an HIV-infected patient receiving antiretrovirals, anti-HCV therapy and carbamazepine: A ‘tour de force’ for clinical pharmacologists by Burger, David M, Arends, Joop E, Jacobs, Birgit S, van Elst-Laurijsen, Danielle H.M, de Kanter, Clara T.M.M, van Maarseveen, Erik M, Verwey-van Wissen, Corrien P.W.G.M, Hoepelman, Andy I.M

Get full text

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment by Smolders, Elise J., de Kanter, Clara T. M. M., van Hoek, Bart, Arends, Joop E., Drenth, Joost P. H., Burger, David M.

Get full text

Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations by de Kanter, Clara T. M. M., Drenth, Joost P. H., Arends, Joop E., Reesink, Henk W., van der Valk, Marc, de Knegt, Robert J., Burger, David M.

Get full text

Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis by Nijstad, A. Laura, van Eijkelenburg, Natasha K. A., Kraal, Kathelijne C. J. M., Meijs, Marieke J. M., de Kanter, Clara T. M. M., Lilien, Marc R., Huitema, Alwin D. R.

Get full text

Pharmacological protection of the thyroid gland against radiation damage from radioactive iodine labeled compounds in children: a systematic review by de Lijster, Bas, de Kanter, Clara T. M. M., de Keizer, Bart, Tytgat, Godelieve A. M., Vulsma, Thomas, Offringa, Martin, van Santen, Hanneke M.

Get full text

Lack of a Clinically Significant Drug—Drug Interaction in Healthy Volunteers Between the Hepatitis C Virus Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir... by de Kanter, Clara T. M. M., Blonk, Maren I., Colbers, Angela P. H., Schouwenberg, Bas J. J. W., Burger, David M.

Get full text

Metformin and daclatasvir: absence of a pharmacokinetic–pharmacodynamic drug interaction in healthy volunteers by Smolders, Elise J., Colbers, Angela, Kanter, Clara T. M. M., Velthoven‐Graafland, Kirsten, Wolberink, Leonie T., Ewijk‐Beneken Kolmer, Noor, Drenth, Joost P. H., Aarnoutse, Rob E., Tack, Cees J., Burger, David M.

Get full text

The majority of hepatitis C patients treated with direct acting antivirals are at risk for relevant drug-drug interactions by Smolders, Elise J, Berden, Floor AC, de Kanter, Clara TMM, Kievit, Wietske, Drenth, Joost PH, Burger, David M

Request full text

Lack of a clinically significant drug-drug interaction in healthy volunteers between the HCV protease inhibitor boceprevir and the proton pump inhibitor omeprazole by de Kanter, Clara T M M, Colbers, Angela P H, Blonk, Maren I, Verweij-van Wissen, Corrien P W G M, Schouwenberg, Bas J J W, Drenth, Joost P H, Burger, David M

Get full text

The ARRIBA concept: adequate resorption of ribavirin by de Kanter, Clara T M M, Koning, Ludi, Berden, Floor A C, Wasmuth, Jan-Christian, Grintjes-Huisman, Karin J T, Becker, Brigitta, Colbers, Angela P H, Roukens, Monique M B, Rockstroh, Jürgen K, Drenth, Joost P H, de Knegt, Robert J, Dofferhoff, Anton S M, Burger, David M

Get full text